Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy

American Journal of Epidemiology

Volumn 172, Issue 11, 2010, Pages 1230-1237

  Andersen, Camilla Schou ^a   Fei, Chunyuan ^b   Gamborg, Michael ^a   Nohr, Ellen Aagaard ^c   Sørensen, Thorkild I A ^a   Olsen, Jørn ^b  

^a The Capital Region   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

body mass index; body weight; growth; infant; prenatal exposure delayed effects

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

BODY MASS; FLUOROCARBON; INFANT MORTALITY; PERSISTENCE; PLASMA; PREGNANCY; REGRESSION ANALYSIS;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DENMARK; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANCY; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MULTIPLE LINEAR REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PRENATAL EXPOSURE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ALKANESULFONIC ACIDS; ANTHROPOMETRY; BIRTH WEIGHT; BREAST FEEDING; COHORT STUDIES; DENMARK; ENVIRONMENTAL MONITORING; FEMALE; FLUOROCARBONS; GROWTH; HUMANS; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; OCTANOIC ACIDS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX FACTORS;

DENMARK;

EID: 78649661901     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq289     Document Type: Article

References (44)

1. Jensen AA, Leffers H. Emerging endocrine disrupters: per-fluoroalkylated substances. Int J Androl. 2008;31(2):161-169.
2. Butenhoff JL, Kennedy GL Jr, Frame SR, et al. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology. 2004;196(1-2):95-116.
3. Halldorsson TI, Fei C, Olsen J, et al. Dietary predictors of perfluorinated chemicals: a study from the Danish National Birth Cohort. Environ Sci Technol. 2008;42(23): 8971-8977.
4. Lau C, Butenhoff JL, Rogers JM. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol. 2004;198(2):231-241.
5. Schecter A, Colacino J, Haffner D, et al. Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ Health Perspect. 2010;118(6):796-802.
6. Apelberg BJ, Goldman LR, Calafat AM, et al. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol. 2007;41(11):3891-3897.
7. Olsen GW, Butenhoff JL, Zobel LR. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol. 2009;27(3-4):212-230.
8. Grandjean P, Bellinger D, Bergman A, et al. The faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol. 2008;102(2):73-75.
9. Case MT, York RG, Christian MS. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol. 2001;20(2):101-109.
10. Lau C, Thibodeaux JR, Hanson RG, et al. Exposure to per-fluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci. 2003;74(2):382-392. (Pubitemid 36958307)
11. Lau C, Thibodeaux JR, Hanson RG, et al. Effects of per-fluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci. 2006;90(2):510-518.
12. Luebker DJ, York RG, Hansen KJ, et al. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology. 2005;215(1-2): 149-169.
13. Washino N, Saijo Y, Sasaki S, et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect. 2009;117(4):660-667.
14. Wolf CJ, Fenton SE, Schmid JE, et al. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci. 2007; 95(2):462-473.
15. Liu C, Du Y, Zhou B. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepato-cytes. Aquat Toxicol. 2007;85(4):267-277.
16. Shi Z, Zhang H, Liu Y, et al. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol Sci. 2007;98(1):206-215.
17. Olsen J, Melbye M, Olsen SF, et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health. 2001;29(4):300-307.
18. Nohr EA, Frydenberg M, Henriksen TB, et al. Does low participation in cohort studies induce bias? Epidemiology. 2006; 17(4):413-418.
19. Fei C, McLaughlin JK, Tarone RE, et al. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect. 2007;115(11): 1677-1682.
20. Fei C, McLaughlin JK, Tarone RE, et al. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol. 2008;168(1): 66-72.
21. Ehresman DJ, Froehlich JW, Olsen GW, et al. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluor-ooctanoate (PFOA), and other fluorochemicals. Environ Res. 2007;103(2):176-184.
22. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: World Health Organization 2000.
23. Ishibashi H, Ishida H, Matsuoka M, et al. Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro. Biol Pharm Bull. 2007;30(7):1358-1359.
24. Wei Y, Dai J, Liu M, et al. Estrogen-like properties of per-fluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). Environ Toxicol Chem. 2007;26(11):2440-2447.
25. Biegel LB, Liu RC, Hurtt ME, et al. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol Appl Pharmacol. 1995;134(1): 18-25.
26. Olsen GW, Burlew MM, Burris JM, et al. A Cross-Sectional Analysis of Serum Perfluorooctanesulfonate (PFOS) and Per-fluorooctanoate (PFOA) in Relation to Clinical Chemistry, Thyroid Hormone, Hematology and Urinalysis Results from Male and Female Employee Participants of the 2000 Antwerp and Decatur Fluorochemical Medical Surveillance Program. 3M Company. Final report. October 11, 2001. US EPA Administrative Record, AR-226-1087. Washington, DC: US Environmental Protection Agency; 2001.
27. Melzer D, Rice N, Depledge MH, et al. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118(5):686-692.
28. Kennedy GL Jr, Butenhoff JL, Olsen GW, et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol. 2004;34(4): 351-384.
29. Loveless SE, Finlay C, Everds NE, et al. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology. 2006;220(2-3):203-217.
30. Peraza MA, Burdick AD, Marin HE, et al. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci. 2006;90(2):269-295.
31. Sohlenius AK, Andersson K, Bergstrand A, et al. Effects of perfluorooctanoic acid-a potent peroxisome proliferator in rat-on Morris hepatoma 7800C1 cells, a rat cell line. Biochim Biophys Acta. 1994;1213(1):63-74.
32. Gilliland FD, Mandel JS. Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men. Am J Ind Med. 1996;29(5): 560-568.
33. Nelson JW, Hatch EE, Webster TF. Exposure to polyfluor-oalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect. 2010;118(2):197-202.
34. Olsen GW, Burris JM, Burlew MM, et al. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med. 2003;45(3): 260-270.
35. Steenland K, Fletcher T, Savitz D. Status Report: Association of Perfluorooctanic Acid (C8/PFOA) and Perfluoroctanesul-fonate (PFOS) with Lipids Among Children in the Mid-Ohio Valley. Morgantown, WV: West Virginia University; 2009. (http://www.c8sciencepanel.org/pdfs/Status-Report-C8- and-lipids-in-children-28Oct2009.pdf).
36. Steenland K, Tinker S, Frisbee S, et al. Association of per-fluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol. 2009;170(10):1268-1278.
37. Apelberg BJ, Witter FR, Herbstman JB, et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and per-fluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect. 2007;115(11):1670-1676.
38. Grice MM, Alexander BH, Hoffbeck R, et al. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med. 2007;49(7): 722-729.
39. Nolan LA, Nolan JM, Shofer FS, et al. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol. 2009;27(3-4):231-238.
40. Inoue K, Okada F, Ito R, et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect. 2004;112(11):1204-1207.
41. Stein CR, Savitz DA, Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol. 2009;170(7): 837-846.
42. Kärrman A, Ericson I, van Bavel B, et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect. 2007;115(2): 226-230.
43. Midasch O, Drexler H, Hart N, et al. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health. 2007;80(7): 643-648.
44. So MK, Yamashita N, Taniyasu S, et al. Health risks in infants associated with exposure to perfluorinated compounds in hu man breast milk from Zhoushan, China. Environ Sci Technol. 2006;40(9):2924-2929.